Shilpa Medicare

Shilpa Medicare is a leading global pharmaceutical company specializing in contract development and manufacturing services for small and large molecules. With a strong emphasis on oncology and a growing presence in biologics, the company offers comprehensive solutions from discovery to commercial supply. Shilpa Medicare operates world-class R&D and manufacturing facilities, serving partners across North America, Europe, and Asia.

Weißraum

News from this company

News

Shilpa Secures SEC, CDSCO Approval for New IND Tablets in NAFLD

17.04.2025 -

Shilpa Medicare has received approval from India’s top drug authorities to move forward with its new IND - Nor-Ursodeoxycholic Acid (500 mg).

Contact

Shilpa Medicare

Karnataka
India